Summary of project PR000341

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000341. The data can be accessed directly via it's Project DOI: 10.21228/M8989V This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR000341
Project DOI:doi: 10.21228/M8989V
Project Title:Metabolomics Analysis of Triple Negative Breast Cancer Cell Lines
Project Type:Metabolomics Analysis
Project Summary:To date there are no clinically approved targeted therapies for triple negative breast cancer (TNBC). In addition to the absence of estrogen, progesterone, and HER2/neu receptors, TNBCs possess characteristics that make them some of the most aggressive forms of breast cancer (BCa). In terms of epidemiology, breast cancers with the triple negative profile present at a higher prevalence in premenopausal women under the age of 40, usually with a BMI greater than 30, and have higher incidences of mutations in BRCA1 or BRCA2 genes. Additionally, several studies have shown a higher prevalence in African American women, demonstrating a health disparity. In spite of this knowledge and the fact that most people respond to initial chemotherapeutic treatment, lasting treatment modalities used for the cure and maintenance of other BCa subtypes generally fail to significantly increase disease-free survival or diminish the rates of recurrence within the first five years after initial detection of TNBC. Our ultimate goal is to identify novel biomarkers which may be leveraged for initiating prevention strategies in high risk populations, earlier detection, or targeted treatment of this disease.
Institute:RTI International
Department:Discovery Sciences
Laboratory:STS/NIH Eastern Regional Comprehensive Metabolomics Resource Core (RTI RCMRC)
Last Name:Delisha
First Name:Stewart
Address:3040, East Cornwallis Road, Research Triangle Park, NC 27709
Email:dstewart@rti.org
Phone:919-541-7204
Funding Source:Internal IR&D (RTI International) and RCMRC
Publications:J. Proteome Res., Article ASAP

Summary of all studies in project PR000341

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
Release
Date
VersionSamplesDownload
(* : Contains raw data)
ST000442 Metabolomics Analysis of Triple Negative Breast Cancer (BCa) Cell Lines Homo sapiens University of North Carolina NMR 2016-12-22 1 24 Uploaded data (9.7M)*
  logo